Cervical screening: A new way forward (tests of risk and tests of disease)

John J. O'Leary,Christine White,Cathy Spillane, Padma Naik,Roisin O'Brien,Stephen Reynolds, Trin Pham,Loretto Pilkington,Imogen Sharkey Ochoa,Noel Bolger,Jacqui Barry O'Crowley,Prerna Tewari,Sharon O'Toole,Mary Rose Sweeney,Helen Keegan,Charles Normand,Linda Sharp,Grainne Flannelly,Cara Martin

HRB open research（2018）

引用 2|浏览2

暂无评分

摘要

Cervical screening has been a highly successful health promotion initiative. The way cervical screening is delivered is about to change dramatically, with the introduction of 'tests of risk' and 'tests of disease' based on primary HPV testing and the use of cell host response biomarkers. This article addresses the fundamental basis of this change in clinical practice and offers insights into how the future of cervical screening will look.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要